PRSS3 and non-small cell lung carcinoma: In analyses including all NSCLC patients, PRSS3 gene expression showed highly significant association with both poor OS (HR 1.47, P = 2.6e-7; Fig. 1a) and poor PFS (HR 2.15, P = 2.7e-11; Fig. 1b).